Cargando…

Schistosoma haematobium infections among schoolchildren in central Sudan one year after treatment with praziquantel

BACKGROUND: Chemotherapy with praziquantel (PZQ) is the mainstay of schistosomiasis control. However, there are recent concerns about tolerance or resistance to PZQ, so that monitoring its efficacy in different settings is required. METHODS: A longitudinal study was conducted to evaluate the impact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmed, Abedaziz M, Abbas, Hana, Mansour, Fathi A, Gasim, Gasim I, Adam, Ishag
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434009/ https://www.ncbi.nlm.nih.gov/pubmed/22676052 http://dx.doi.org/10.1186/1756-3305-5-108

Ejemplares similares

A Praziquantel Treatment Study of Immune and Transcriptome Profiles in Schistosoma haematobium-Infected Gabonese Schoolchildren
por: Labuda, Lucja A, et al.
Publicado: (2019)

Antenatal iron and folic acid supplementation use by pregnant women in Khartoum, Sudan
por: Abdullahi, Hala, et al.
Publicado: (2014)

Efficacy and safety of artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Sudan: a systematic review and meta-analysis
por: Adam, Ishag, et al.
Publicado: (2018)

Prevalence and intensity of Schistosoma haematobium infection among schoolchildren in central Zambia before and after mass treatment with a single dose of praziquantel
por: Shehata, Mohamed A., et al.
Publicado: (2018)

Pattern and Trends in Adult Hospitalization/Admission and Mortality Among Medical Ward Inpatients at Gadarif Hospital in Eastern Sudan: A Four-Year Retrospective Study
por: Omar, Saeed M, et al.
Publicado: (2022)

Severe Plasmodium vivax malaria among sudanese children at New Halfa Hospital, Eastern Sudan
por: Mahgoub, Hyder, et al.
Publicado: (2012)

Praziquantel, Mefloquine-Praziquantel, and Mefloquine-Artesunate-Praziquantel against Schistosoma haematobium: A Randomized, Exploratory, Open-Label Trial
por: Keiser, Jennifer, et al.
Publicado: (2014)

Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya.
por: King, C H, et al.
Publicado: (2000)

Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya.
por: Coles, G C, et al.
Publicado: (2001)

Efficacy of Praziquantel against Schistosoma haematobium in Dulshatalo village, western Ethiopia
por: Mekonnen, Asaye, et al.
Publicado: (2013)

Poor adherence to the malaria management protocol among health workers attending under-five year old febrile children at Omdurman Hospital, Sudan
por: Bilal, Jalal A, et al.
Publicado: (2015)

Efficacy of Artesunate + Sulfamethoxypyrazine/Pyrimethamine versus Praziquantel in the Treatment of Schistosoma haematobium in Children
por: Sissoko, Mahamadou S., et al.
Publicado: (2009)

Efficacy of artemether-lumefantrine as a treatment for uncomplicated Plasmodium vivax malaria in eastern Sudan
por: Abdallah, Tajeldin M, et al.
Publicado: (2012)

Diagnosis of Trichomonous vaginalis by microscopy, latex agglutination, diamond’s media, and PCR in symptomatic women, Khartoum, Sudan
por: Saleh, Amir M, et al.
Publicado: (2014)

The Life Histories of Intermediate Hosts and Parasites of Schistosoma haematobium and Schistosoma mansoni in the White Nile River, Sudan
por: Ismail, Hassan Ahmed Hassan Ahmed, et al.
Publicado: (2022)

Schistosoma haematobium Treatment in 1–5 Year Old Children: Safety and Efficacy of the Antihelminthic Drug Praziquantel
por: Mutapi, Francisca, et al.
Publicado: (2011)

Efficacy and safety of praziquantel against Schistosoma haematobium in the Ikata-Likoko area of southwest Cameroon
por: Ebai, Calvin Bisong, et al.
Publicado: (2017)

Organomegaly in Mali before and after praziquantel treatment. A possible association with Schistosoma haematobium
por: Stecher, Chalotte Willemann, et al.
Publicado: (2017)

Genetic Diversity of Schistosoma haematobium Eggs Isolated from Human Urine in Sudan
por: Quan, Juan-Hua, et al.
Publicado: (2015)

In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium
por: Kovač, Jana, et al.
Publicado: (2017)

Efficacy and Safety of Praziquantel in Preschool-Aged Children in an Area Co-Endemic for Schistosoma mansoni and S. haematobium
por: Coulibaly, Jean T., et al.
Publicado: (2012)

Genetic diversity of Schistosoma haematobium parasite IS NOT associated with severity of disease in an endemic area in Sudan
por: Gasmelseed, Nagla, et al.
Publicado: (2014)

Schistosoma haematobium
por: Corsini Campioli, Cristina, et al.
Publicado: (2022)

Patterns of Schistosoma haematobium infection, impact of praziquantel treatment and re-infection after treatment in a cohort of schoolchildren from rural KwaZulu-Natal/South Africa
por: Saathoff, Elmar, et al.
Publicado: (2004)

Schistosoma haematobium infection levels determine the effect of praziquantel treatment on anti-schistosome and anti-mite antibodies
por: RUJENI, N, et al.
Publicado: (2012)

Safety, efficacy and acceptability of praziquantel in the treatment of Schistosoma haematobium in pre-school children of Kwale County, Kenya
por: Kimani, Bridget W., et al.
Publicado: (2018)

Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon
por: Dejon-Agobé, Jean Claude, et al.
Publicado: (2019)

Urinary cytokines in Schistosoma haematobium-infected schoolchildren from Tana Delta District of Kenya
por: Njaanake, Kariuki H, et al.
Publicado: (2014)

Schistosomiasis, hepatitis B and hepatitis C co-infection
por: Gasim, Gasim I, et al.
Publicado: (2015)

Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial
por: Barda, Beatrice, et al.
Publicado: (2016)

Dynamics of Schistosoma haematobium egg output and associated infection parameters following treatment with praziquantel in school-aged children
por: Stete, Katarina, et al.
Publicado: (2012)

Efficacy of praziquantel in the treatment of Schistosoma haematobium infection among school-age children in rural communities of Abeokuta, Nigeria
por: Ojurongbe, Olusola, et al.
Publicado: (2014)

Impact of Single Dose Praziquantel Treatment on Schistosoma haematobium Infection among School Children in an Endemic Nigerian Community
por: Adewale, Babatunde, et al.
Publicado: (2018)

Correction to: Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon
por: Dejon-Agobé, Jean Claude, et al.
Publicado: (2021)

Co-infection with Schistosoma haematobium modulates the gene expression profile of malaria infection in schoolchildren in Gabon
por: Ewer, Katie, et al.
Publicado: (2014)

Spatial distribution and risk factors of Schistosoma haematobium and hookworm infections among schoolchildren in Kwale, Kenya
por: Chadeka, Evans Asena, et al.
Publicado: (2017)

Three monthly doses of 60 mg/kg praziquantel for Schistosoma haematobium infection is a safe and effective treatment regimen
por: Darko, Samuel Nkansah, et al.
Publicado: (2020)

Accuracy of tympanic temperature measurement using an infrared tympanic membrane thermometer
por: Gasim, Gasim I, et al.
Publicado: (2013)

O Blood Group as Risk Factor for Preeclampsia among Sudanese Women
por: Elmugabil, Abdelmageed, et al.
Publicado: (2016)

Helicobacter pylori infection, gestational diabetes mellitus and insulin resistance among pregnant Sudanese women
por: Alshareef, Shimos A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pq94jdiah5qa3oig5df5ovkqma